ReviewCurrent hematologic malignancy reports2022
Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors.
Julian A Waksal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewCurrent hematologic malignancy reports2022
Julian A Waksal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.